AI in healthcare: applications and best practices

AI in healthcare: applications and best practices | Databricks Blog

Skip to main content

AI in healthcare spans diagnostic imaging, clinical documentation, drug discovery, and administrative automation, with adoption accelerating fastest in radiology, where AI medical devices are concentrated.

Regulatory obligations are tightening, with the European AI Act reaching full applicability in 2026 and classifying most clinical AI systems as high-risk, alongside existing HIPAA data protection requirements.

Responsible deployment depends on human oversight, bias-tested training data, and staged validation, since AI systems are designed to support, not replace, clinical judgment.

AI in healthcare refers to the application of artificial intelligence, including machine learning, deep learning, and generative AI, to clinical, administrative, and research workflows across healthcare systems. Healthcare AI systems ingest patient data, electronic health records, medical imaging, and clinical documentation to support diagnosis, treatment planning, and operational efficiency. This guide is written for healthcare professionals, health IT leaders, and clinical informatics teams evaluating AI solutions, prioritizing clinical use cases, data practices, and regulatory obligations over vendor comparisons.

Healthcare AI has a longer history than most clinical teams assume. AI began integrating into healthcare in the 1970s, when early rule-based expert systems attempted to replicate physician decision-making for narrow diagnostic tasks. Modern AI models bear little resemblance to those early systems, but the core objective remains the same: using patterns in data to support, not replace, clinical judgment. The sections below cover where AI tools are used today, how organizations manage the training data that powers them, and what regulatory frameworks govern clinical use.

Scope and definitions: artificial intelligence, AI models, and AI algorithms

Artificial intelligence is the broad field of computer science focused on building systems that perform tasks normally requiring human intelligence, such as pattern recognition, language understanding, and prediction. Within healthcare AI, three terms are frequently used interchangeably but describe distinct layers of the technology stack.

AI models are the trained artifacts that map input data, such as patient data or medical images, to an output, such as a risk score or a classification. AI algorithms are the mathematical procedures, including machine learning algorithms and deep learning techniques, used to train those models. Generative AI is a specific category of AI models capable of producing new content, such as clinical documentation drafts or summarized medical history, rather than only classifying or predicting existing data.

Healthcare organizations typically deploy several model types side by side: supervised classification models for diagnostic support, time-series models for patient monitoring, natural language processing models for clinical documentation, and computer vision models for analyzing medical images. Understanding which model type underlies a given AI tool helps clinical teams evaluate its outputs appropriately, since a generative model's fluent text carries different reliability guarantees than a validated diagnostic classifier's output.

Where AI is being used: applications and AI tools in healthcare

AI tools now touch nearly every stage of clinical medicine, from intake to post-discharge monitoring. In healthcare and life sciences organizations, the most mature applications cluster around four categories: diagnostic support, administrative automation, drug discovery, and patient-facing engagement.

Clinical decision support systems flag high-risk patients, surface relevant treatment protocols, and summarize medical history at the point of care. AI algorithms can flag high-risk patients in emergency departments, giving triage staff earlier visibility into deterioration risk than manual chart review allows. Imaging AI tools assist radiologists and pathologists by pre-screening scans and highlighting regions of interest. Administrative AI solutions handle medical coding, claims processing, and prior authorization, reducing the manual burden on healthcare providers.

Virtual health assistants and wearable devices extend AI-driven healthcare beyond the hospital, enabling continuous patient monitoring for chronic conditions. Telehealth platforms increasingly embed AI models directly into the consultation workflow, using natural language processing to generate visit summaries in real time. Across these applications, the common thread is that AI tools are designed to augment clinical practice, surfacing accurate insights faster than manual review while leaving diagnostic and treatment decisions to healthcare professionals.

Electronic health records and AI model training

Electronic health records (EHRs) are the primary data source for most healthcare AI systems. EHR data includes structured fields such as lab results and medication lists alongside unstructured clinical notes, making it a rich but heterogeneous training data source. AI can analyze electronic health records to predict disease risks, identify care gaps, and flag patients who may benefit from earlier intervention.

Effective AI model training on EHR data requires disciplined data collection practices. Healthcare systems need standardized data models, consistent coding practices, and interoperable formats before AI algorithms can reliably learn from historical records. Organizations that centralize EHR data, clinical documentation, and imaging data on a unified data lakehouse architecture avoid the data silos that historically limited healthcare AI projects to single-department pilots.

Interoperability is a second requirement. Health systems exchanging data through modern APIs and FHIR-based standards can train AI models on larger, more representative patient populations, which improves generalizability. AI can predict patient outcomes with 70-72% accuracy using EHR data when models are trained on sufficiently large and diverse datasets, though accuracy varies significantly by condition, data quality, and population represented in training data.

Clinical documentation and generative AI

Clinical documentation is one of the fastest-growing use cases for generative AI in healthcare. Ambient listening tools capture patient encounters and draft structured clinical notes, reducing the time clinicians spend on manual charting. AI can reduce administrative tasks, improving clinician efficiency and giving healthcare providers more direct time with patients.

A typical clinical documentation workflow begins with audio transcription of the patient encounter, followed by a generative AI model that structures the transcript into a formatted note using standard templates. Large language models power most modern transcription and summarization tools, and many implementations also incorporate Retrieval-Augmented Generation (RAG), a technique that grounds a model's output in a verified knowledge base rather than relying solely on the model's internal training. Grounding generated notes against a verified RAG knowledge base reduces the risk of fabricated clinical details appearing in the record.

Clinical validation remains non-negotiable. Every AI-drafted note requires a clinician review checkpoint before it becomes part of the permanent medical record. This human oversight step is not a temporary workaround; it is a permanent feature of responsible clinical documentation AI, since generative models can produce fluent but factually incorrect text, a failure mode that carries direct patient safety implications in a clinical record.

AI tools for medical imaging and diagnostics

Medical imaging is the clinical domain with the deepest track record of regulatory-cleared AI tools. By 2025, 77% of FDA-approved AI medical devices will be in radiology, reflecting both the volume of imaging data available for training and the relatively well-defined nature of image classification tasks compared to more open-ended clinical reasoning.

AI systems now analyze medical images across multiple modalities. Deep learning models trained on CT scans can flag early signs of lung cancer, often identifying nodules smaller or fainter than those reliably caught in manual review. Similar convolutional architectures support diabetic retinopathy screening from retinal photographs and breast cancer detection from mammography, two of the most extensively validated imaging AI use cases in clinical medicine.

When evaluating imaging AI tools, healthcare organizations should confirm FDA clearance or CE marking status, request published sensitivity and specificity data on populations comparable to their own patient base, and establish a workflow where the AI output serves as a second reader rather than a final determination. This approach preserves early detection benefits while keeping accountability with the radiologist or pathologist of record.

Drug discovery and drug interactions

Pharmaceutical research and development represents one of the highest-value applications of AI in healthcare, given the cost and multi-year timelines of traditional drug development. AI can enhance drug discovery processes, speeding up treatment availability by narrowing the search space for viable drug candidates before expensive laboratory validation begins.

AI models in drug discovery

Protein-structure prediction models, most notably AlphaFold and its successors, have changed how research teams approach target identification. Instead of relying solely on experimental crystallography, researchers can generate high-confidence structural predictions computationally, then prioritize wet-lab validation for the most promising targets. This shifts the drug discovery workflow: target identification increasingly begins with a computational model before advancing to biological or biochemical confirmation. AI can reduce drug discovery time significantly during clinical trials, particularly in the early screening phases where AI models filter thousands of candidate compounds down to a shortlist worth pursuing experimentally.

Detecting drug interactions with AI

Literature-mining algorithms scan published clinical research, adverse event reports, and pharmacovigilance databases to identify previously undocumented drug interactions. These AI algorithms process volumes of unstructured medical research text far beyond what manual literature review teams can cover. Integrating drug interaction detection models with adverse event surveillance systems allows healthcare organizations to flag emerging safety signals earlier, supporting both individual patient safety and broader public health monitoring.

Operational AI solutions: administrative tasks and workflows

Administrative burden is consistently cited by healthcare providers as a leading driver of clinician burnout, and AI solutions targeting routine tasks address this directly. AI can reduce administrative burdens for healthcare providers by automating medical coding, insurance eligibility checks, prior authorization documentation, and claims processing.

A typical operational AI deployment maps administrative tasks by volume and complexity, then sequences automation starting with the highest-volume, most rules-based processes, such as coding for routine visits, before advancing to more complex claims scenarios. Workflow diagrams that trace a claim from submission through adjudication help operational teams identify where AI-assisted review reduces denial rates and rework.

Beyond claims, AI-driven resource allocation tools help healthcare systems allocate resources such as staffing, bed capacity, and equipment based on predicted patient volume. Estimating the operational return on investment for these deployments typically involves comparing pre-automation processing time and error rates against post-deployment metrics over a defined pilot period, giving healthcare systems a defensible basis for scaling successful pilots.

Clinical decision support and AI algorithms

Clinical decision support systems apply AI algorithms to synthesize patient data, clinical guidelines, and treatment protocols into actionable recommendations at the point of care. Algorithm types range from rule-based systems, which apply explicit clinical logic, to machine learning algorithms trained on historical outcomes, to more complex deep learning models capable of identifying subtle patterns across high-dimensional data such as continuous vital sign streams.

Explainability is a critical requirement for clinical decision support, distinct from many other AI applications. Healthcare professionals need to understand why an algorithm flagged a particular patient or recommended a specific treatment protocol, not just receive the output itself. Reporting explainability metrics, such as which input variables most influenced a given recommendation, supports clinician trust and satisfies emerging regulatory expectations for high-risk AI systems.

Validation protocols before deployment should include retrospective testing against historical patient outcomes, prospective shadow-mode testing where the algorithm runs alongside standard care without influencing decisions, and ongoing performance monitoring after go-live. This staged validation approach catches performance degradation or bias before it affects patient care.

Read now

Data practices: data collection, privacy, and ehr use

AI systems require high-quality data to ensure accuracy and fairness, which makes data collection standards foundational to any healthcare AI program. Clinical data collection standards should specify acceptable data sources, minimum sample sizes for training data, and documentation requirements for how each dataset was assembled and labeled.

De-identification and pseudonymization are standard practices before healthcare data enters a model training pipeline. Techniques range from simple field removal to more sophisticated approaches that preserve analytical utility while reducing re-identification risk. Organizations operating across the European Union should also account for the European Health Data Space, a framework that enables secondary use of health data for AI research and innovation under defined safeguards, distinct from the primary use of that data in direct patient care.

Cross-border data considerations add further complexity for multinational research consortia. Centralizing patient data on a governed data governance framework, with clear lineage from own data sources through to model training, gives compliance teams the audit trail regulators increasingly require.

Regulation and liability: the AI act and compliance

The regulatory landscape for AI in healthcare has moved from voluntary guidance toward binding legal obligations. The European AI Act will be fully applicable by 2026, and it establishes a risk-tiered regulatory framework in which most clinical AI systems, including diagnostic and treatment-recommendation tools, are classified as high-risk. The AI Act requires high-risk AI systems to meet strict safety standards, including documented risk management, data governance, technical documentation, and human oversight throughout the system's lifecycle.

Obligations differ for general-purpose AI models, such as large language models that healthcare organizations fine-tune or deploy for a specific clinical use, compared to AI systems built for a single defined purpose. General-purpose model providers face transparency and documentation requirements at the model level, while healthcare organizations deploying those models for high-risk clinical use inherit additional obligations as deployers under the regulatory framework.

In the United States, the U.S. FDA is developing frameworks for AI medical devices that account for models capable of continuous learning after initial clearance, a departure from the traditional device approval model built around a fixed, unchanging product. Any healthcare AI deployment handling patient data must also comply with HIPAA regulations to protect patient data, regardless of which clinical regulatory pathway applies. A practical compliance checklist for healthcare AI deployments should confirm HIPAA compliance safeguards, applicable AI Act risk classification, FDA clearance status where relevant, and documented human oversight procedures before go-live.

Implementation framework for AI solutions deployment

Healthcare organizations that succeed with AI solutions typically follow a pilot-to-scale roadmap rather than an enterprise-wide rollout from day one. A pilot phase, scoped to a single clinical service line or administrative workflow, surfaces data quality issues, workflow friction, and clinician adoption barriers before broader investment.

Shadow-mode deployment, where the AI system runs in parallel with existing clinical workflows without influencing live decisions, is the recommended step between pilot and production for any AI tool touching direct patient care. This period allows healthcare systems to compare AI-generated outputs against actual clinical outcomes and manual review, quantifying accuracy before clinicians rely on the system's recommendations.

Stakeholder engagement should extend beyond the informatics team to include practicing clinicians, compliance officers, and patient advocates from the earliest planning stages. A quarterly monitoring cadence ensures an AI tool validated at launch continues to perform reliably as patient populations and underlying data distributions shift over time.

Ethics, bias, and patient safety in AI-driven healthcare

AI integration faces challenges like data privacy and algorithmic bias, and addressing both is a prerequisite for responsible deployment rather than an optional add-on. Bias mitigation strategies should include auditing training data for representativeness across demographic groups, testing model performance separately within subpopulations rather than relying on aggregate accuracy alone, and establishing a process to retrain or retire models that show a performance gap for any patient group.

Human oversight is a requirement, not a recommendation, for high-risk clinical use cases. Every AI-generated recommendation that influences diagnosis or treatment should pass through a healthcare professional before it affects patient care, and that reviewer should have the authority and training to override the system's output. Transparency and consent practices matter equally: patients should be informed when AI tools contribute to their care, in language that explains the AI system's role without requiring technical expertise to understand.

Patient privacy protections extend beyond regulatory compliance into everyday practice, including access controls on who can query patient data and audit logging for every access event. These practices protect individual patients while preserving the trust that population-scale AI-driven healthcare depends on.

Evaluation, monitoring, and performance metrics for AI systems

Clinical performance metrics for healthcare AI extend beyond the accuracy figures typically reported in the AI industry. Sensitivity, specificity, positive predictive value, and calibration across patient subgroups all matter more in a clinical setting than a single aggregate accuracy score. AI can predict disease with 70-72% accuracy in several validated use cases, but that figure means little without corresponding subgroup and calibration data specific to the deployment population.

Real-world evidence collection plans should specify how post-deployment outcomes will be tracked against the model's pre-deployment validation performance. AI tools that predict sepsis hours before symptoms appear, for example, require monitoring not just of prediction accuracy but of downstream clinical response time and patient outcomes following each alert.

Post-deployment monitoring frequency depends on clinical risk level: high-risk decision-support tools warrant continuous monitoring, while lower-risk administrative AI solutions can follow a quarterly review cycle. Tracking data and model versions through MLflow gives clinical and compliance teams a reproducible record of which model version produced a given recommendation.

Workforce, training, and career opportunities in healthcare AI

AI-driven healthcare is reshaping the skills healthcare professionals need, without eliminating the clinical judgment at the center of patient care. Clinicians increasingly need working fluency in how AI models generate their outputs, what data collection and training data limitations might affect reliability, and how to escalate when an AI tool's recommendation conflicts with clinical judgment.

Training modules for clinical staff should cover practical AI literacy: interpreting model confidence scores, recognizing failure modes such as demographic bias, and understanding the boundaries of what a given AI tool was validated to do. Interdisciplinary roles are emerging at the intersection of clinical medicine and data science, including clinical informaticists, health data governance specialists, and AI implementation leads responsible for the pilot-to-scale process described above. Healthcare systems investing in this capability now are better positioned to evaluate new AI tools critically as healthcare AI innovation accelerates.

Future trends: generative AI and advanced AI models in healthcare

AI is expected to enhance personalized medicine by 2025, tailoring treatment protocols to individual patients based on genomic, clinical, and lifestyle data rather than population averages. AI will enable precision medicine tailored to individual patients as multi-modal AI models mature enough to reason jointly across medical imaging, structured EHR data, and genomic data within a single system, rather than requiring separate models for each data type.

Generative AI's role in clinical workflows is also expected to expand beyond documentation into areas such as synthetic training data generation, which can help address data scarcity for rare disease research while preserving patient privacy. AI is expected to create $60-110 billion in annual value for healthcare, a figure driven by combined gains across administrative efficiency, clinical decision support, and accelerated drug discovery rather than any single application.

Ongoing research coverage should track emerging AI models capable of processing multiple data modalities simultaneously, updated regulatory guidance as the AI Act's provisions reach full applicability, and evolving evidence on where AI-driven healthcare measurably improves patient outcomes at scale versus where further validation is still needed.

Frequently asked questions

How is AI used in healthcare today?

AI in healthcare supports clinical decision-making, medical imaging analysis, clinical documentation, administrative automation, and drug discovery. Healthcare providers use AI tools to flag high-risk patients, draft clinical notes from patient encounters, and screen medical images for early signs of disease, always with human oversight before findings affect patient care.

How accurate is AI at predicting patient outcomes?

AI can predict patient outcomes with 70-72% accuracy using electronic health records, though accuracy varies by condition, data quality, and the diversity of the training data. Healthcare organizations should request subgroup-level performance data, not just an aggregate accuracy figure, before relying on any predictive model in clinical practice.

What is the european AI act's impact on healthcare ai?

The European AI Act classifies most clinical AI systems as high-risk and will be fully applicable by 2026. It requires healthcare organizations deploying high-risk AI systems to maintain documented risk management, data governance, technical documentation, and human oversight throughout each system's lifecycle.

Does  reAIplace healthcare professionals?

No. AI systems are designed to support, not replace, clinical judgment. Human oversight is required for high-risk clinical use cases, meaning a healthcare professional reviews AI-generated recommendations before they influence diagnosis or treatment decisions for individual patients.

How does AI protect patient privacy in healthcare settings?

AI systems handling patient data must comply with HIPAA regulations in the United States and equivalent frameworks such as the European Health Data Space elsewhere. Healthcare organizations apply de-identification, pseudonymization, and access controls to patient data before it enters AI model training pipelines.

What data do AI models need for healthcare applications?

Healthcare AI models train on electronic health records, medical imaging, clinical documentation, and, increasingly, wearable device data. AI systems require high-quality, representative training data to ensure accuracy and fairness across the patient populations the model will ultimately serve.

Resources, references, and further reading

Healthcare organizations building or evaluating AI capabilities should track regulatory guidance from the FDA's evolving AI medical device framework and the European Commission's AI Act implementation timeline, alongside benchmark datasets commonly used to evaluate model performance in radiology, clinical NLP, and predictive analytics. Databricks supports healthcare industry organizations building governed, production-scale AI systems on a unified data lakehouse architecture, with Unity Catalog providing the governance layer that underpins compliant AI model training across clinical and research data.

Get the latest posts in your inbox

Subscribe to our blog and get the latest posts delivered to your inbox.

Sign up

View all blogs